DrugRisk Adds Latest Information For Yaz Blood Clot Lawsuits

Share Article

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

YAZ LAWSUIT
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The prescription drug resource center DrugRisk.com is alerting women who have taken the birth control drugs Yaz or Yasmin that information about Yaz lawsuits has been updated after a major health insurer joined the blood clot litigation against Bayer.

“DrugRisk’s mission is to improve patient safety by providing the public with the latest medication warnings, recalls, studies and litigation news. Since the same drugs are often prescribed around the world, this can include news from other countries as well,” explains DrugRisk representative Ryan Mayer.

The resource center previously added news that thousands of patients had filed a Yaz lawsuit over blood clots in the U.S. These have been consolidated to a special Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Now, DrugRisk has added new information showing Switzerland’s largest health insurer, CSS, has joined in a case filed there by a young women who suffered pulmonary embolism after taking Yasmin, with weeks of hospitalization costing over $600,000.*

DrugRisk has learned that Bayer’s latest financial statements show they have spent almost $750 million to settle around 3,500 Yaz lawsuits for blood clot injuries at an average of or around $214,000 per case.** The company has also set aside more funds for additional claims.

The resource center recently added a warning from France’s Health Ministry that they will stop reimbursements for oral contraceptives like Yaz and Yasmin in March over concerns that the drugs increase risks of blood clots.***

Last fall, The American College of Obstetricians and Gynecologists also warned that birth control pills containing drospirenone, such as Yaz and Yasmin, may have a higher risk of causing blood clots.****

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The Drug Risk Resource Center cautions victims who wish to learn about their legal options that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Reuters: “Swiss health insurer makes claim against Bayer over Yasmin pill,” January 9, 2013
**Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012
*** reuters.com/article/2013/01/03/france-contraception-idUSL5E9C31XG20130103
****Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website